Cliniques Universitaires Saint-Luc ASBL

Cliniques Universitaires Saint-Luc ASBL is an organisation in Bruxelles / Brussel, Belgium that has taken part in 30 EU-funded projects since 2009, receiving €5.0M in EU funding.

EU funding received€5.0M
EU projects30
As coordinator0
Running now14
First EU project2009
Latest project2027
CountryBelgium
EU registration (PIC)998753226
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cliniques Universitaires Saint-Luc ASBL's own share of each project, not the project's full budget.

  • Horizon 2020€2.0M · 13 projects
  • FP7 (2007 to 2013)€1.6M · 3 projects
  • Horizon Europe€1.0M · 9 projects
  • EU4Health Programme (EU4H)€327k · 3 projects
  • Interregional Innovation Investments Instrument (I3)€80k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

30 EU-funded projects, newest first. Each links to the official record.

  • TIE2getherAssociated partner

    Next-generation therapeutics for vascular diseases

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

  • BodyCraveAssociated partner

    Craving in the Body

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • COMPASSAssociated partner

    Cardio-Oncology Multidisciplinary Patient ASsistance Solution

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • JA PCMAssociated partner

    Joint Action Personalised Cancer Medicine

    EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

    €64ktheir share
  • MDR-RAPartner

    Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €213ktheir share
  • EUmetriosisAssociated partner

    EUmetriosis: Transforming endometriosis care in Europe: an integrated approach to enhance understanding, diagnosis, tailored management and patient empowerment

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • JANE-2Associated partner

    Joint Action on Networks of Expertise on Cancer

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €178ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €85ktheir share
  • ARTEMISPartner

    AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €297ktheir share
  • e-QuoLPartner

    e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €159ktheir share
  • CU2030Associated partner

    Circle U. 2030

    Erasmus+ (ERASMUS+) · 2023–2027 · Project on the EU portal ↗

  • DigiONE I3Partner

    DIGItal Infrastructure for ONcology in Europe

    Interregional Innovation Investments Instrument (I3) · 2023–2026 · Project on the EU portal ↗

    €80ktheir share
  • CARE1Associated partner

    First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • HT-ADVANCEPartner

    Improving treatment efficacy in hypertension by biomarker-guided personalised decision support

    Horizon Europe · 2023–2029 · Project on CORDIS ↗

    €354ktheir share
  • TIGERPartner

    Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €311ktheir share
  • QSPainReliefPartner

    Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach.

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €68ktheir share
  • 3TRPartner

    Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

    Horizon 2020 · 2019–2028 · Project on CORDIS ↗

    €434ktheir share
  • V.A. CurePartner

    A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  • IMMUcanPartner

    Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €30ktheir share
  • IMI-PainCarePartner

    Improving the care of patients suffering from acute or chronic pain

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €134ktheir share
  • IMMUNOSABRPartner

    Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

    €115ktheir share
  • Microbes4UAssociated partner

    Study of the therapeutic potential of an Akkermansia muciniphila-based products in subjects with an increased cardio-metabolic risk.

    Horizon 2020 · 2016–2017 · Project on CORDIS ↗

  • SPCCTPartner

    In Vivo Spectral Photon Counting CT Molecular Imaging in Cardio- and Neuro-Vascular Diseases

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €97ktheir share
  • ChiLTERNPartner

    Children’s Liver Tumour European Research Network

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €236ktheir share
  • SEPCELLPartner

    Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje

    Horizon 2020 · 2015–2022 · Project on CORDIS ↗

    €534ktheir share
  • OPERAMAssociated partner

    OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

  • BETA3_LVHAssociated partner

    A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

    Horizon 2020 · 2015–2022 · Project on CORDIS ↗

  • COMBACTE-MAGNETPartner

    Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections

    FP7 (2007 to 2013) · 2015–2021 · Project on CORDIS ↗

    €663ktheir share
  • COMBACTE-NETPartner

    Combatting Bacterial Resistance in Europe

    FP7 (2007 to 2013) · 2013–2021 · Project on CORDIS ↗

    €719ktheir share
  • SAGHEPartner

    Safety and Appropriateness of Growth hormone treatments in Europe

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €250ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alcohols
  • antibiotic resistance
  • antibiotics
  • arteriosclerosis
  • bacteriology
  • cardiology
  • cardiovascular diseases
  • computed tomography
  • critical care medicine
  • data science
  • databases
  • diabetes
  • drug discovery
  • eHealth

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime